AI Coding Agents Struggle with Precise Code Localization, Study Reveals
A new benchmark, SWE-Explore, indicates that while AI coding agents can identify the correct files, they often miss critical lines of code, impacting their ability…
Read moreDesk archive
AI product, policy, startup and adoption news with India context.
A new benchmark, SWE-Explore, indicates that while AI coding agents can identify the correct files, they often miss critical lines of code, impacting their ability…
Read more
Procter & Gamble Hygiene and Health Care Limited has announced Mohit Pradhan will lead its Feminine Hygiene business as Vice President and Category Leader, effective…
Read more
Professional services giant KPMG has retracted a report on AI usage after claims made about several organisations were found to be untrue, with inaccuracies attributed…
Read more
Amazon CEO Andy Jassy reportedly flagged security vulnerabilities in Anthropic's AI models to US Treasury officials, leading to an export ban on Claude Fable 5…
Read more
A new AI model named "Count Anything," developed by researchers from Tsinghua University and other institutions, aims to reliably count objects in any image type,…
Read more
A coalition of US state attorneys general has reportedly launched an investigation into OpenAI, scrutinizing its advertising practices, user data handling, and treatment of minors.
Read more
Google Research's Gemini-SQL2, powered by Gemini 1.5 Pro, has significantly outperformed competitors in text-to-SQL benchmarks, achieving 80.04% accuracy on the BIRD benchmark. This advancement allows…
Read more
Microsoft, in collaboration with Chinese universities, has developed SkillOpt, a novel method that significantly boosts AI agent performance using optimized Markdown instruction files. This approach…
Read more
Apple's new Siri AI, powered by Google Gemini, is set to redefine how users interact with information, potentially impacting search visibility and digital strategies for…
Read more
Bengaluru-based Zumutor Biologics has secured $7.3 million in Series B funding to accelerate clinical trials for its cancer immunotherapies, including initiating global Phase 2 studies…
Read more